{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T21:02:07Z","timestamp":1791061327743,"version":"4.1.0"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100014434","name":"Narodowa Agencja Wymiany Akademickiej","doi-asserted-by":"publisher","award":["PPI\/STE\/2020\/1\/00014\/DEC\/02"],"award-info":[{"award-number":["PPI\/STE\/2020\/1\/00014\/DEC\/02"]}],"id":[{"id":"10.13039\/501100014434","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","clinicalnutritionespen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition ESPEN"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.clnesp.2024.11.016","type":"journal-article","created":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T02:51:23Z","timestamp":1733280683000},"page":"424-444","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Efficacy of probiotics regimens for Helicobacter pylori eradication: A\u00a0systematic review, pairwise, and network meta-analysis of randomized controlled trials"],"prefix":"10.1016","volume":"65","author":[{"given":"Mohammad","family":"Tanashat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Abuelazm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Abouzid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yazan A.","family":"Al-Ajlouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa","family":"Ramadan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumaya","family":"Alsalah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulrahman","family":"Sharaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Ayman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hesham","family":"Elharti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Zhana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Obieda","family":"Altobaishat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basel","family":"Abdelazeem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4176-0332","authenticated-orcid":false,"given":"Fouad","family":"Jaber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.clnesp.2024.11.016_bib1","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S1470-2045(12)70137-7","article-title":"Global burden of cancers attributable to infections in 2008: a review and synthetic analysis","volume":"13","author":"de Martel","year":"2012","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.clnesp.2024.11.016_bib2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/gutjnl-2016-312288","article-title":"Management of Helicobacter pylori infection-the maastricht V\/florence consensus report","volume":"66","author":"Malfertheiner","year":"2017","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.clnesp.2024.11.016_bib3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13099-023-00539-y","article-title":"The benefit of the bismuth add-on to the 2-week clarithromycin-based triple regimen for Helicobacter pylori eradication: a propensity score-matched retrospective study","volume":"15","author":"Shin","year":"2023","journal-title":"Gut Pathog"},{"issue":"5","key":"10.1016\/j.clnesp.2024.11.016_bib4","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1111\/j.1572-0241.2001.03788.x","article-title":"Retreatment of Helicobacter pylori infection after initial treatment failure","volume":"96","author":"Kearney","year":"2001","journal-title":"Am J Gastroenterol"},{"issue":"15","key":"10.1016\/j.clnesp.2024.11.016_bib5","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1056\/NEJMra020542","article-title":"Helicobacter pylori infection","volume":"347","author":"Suerbaum","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.clnesp.2024.11.016_bib6","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1136\/gut.2006.101634","article-title":"Current concepts in the management of Helicobacter pylori infection: the maastricht III consensus report","volume":"56","author":"Malfertheiner","year":"2007","journal-title":"Gut"},{"issue":"3 Suppl 2","key":"10.1016\/j.clnesp.2024.11.016_bib7","first-page":"812s","article-title":"Helicobacter pylori and probiotics","volume":"137","author":"Lesbros-Pantoflickova","year":"2007","journal-title":"J\u00a0Nutr"},{"issue":"3","key":"10.1016\/j.clnesp.2024.11.016_bib8","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.gastrohep.2017.08.005","article-title":"Eradication of Helicobacter pylori infection with a new bismuth-based quadruple therapy in clinical practice","volume":"41","author":"P\u00e9rez-Arellano","year":"2018","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.clnesp.2024.11.016_bib9","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/1221190","article-title":"Effects of quadruple therapy combined with probiotics on Helicobacter pylori-related peptic ulcer","volume":"2022","author":"Zhou","year":"2022","journal-title":"Comput Math Methods Med"},{"issue":"40","key":"10.1016\/j.clnesp.2024.11.016_bib10","doi-asserted-by":"crossref","first-page":"14527","DOI":"10.3748\/wjg.v20.i40.14527","article-title":"Evidence-based assessment of proton-pump inhibitors in Helicobacter pylori eradication: a systematic review","volume":"20","author":"Nagaraja","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.clnesp.2024.11.016_bib11","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12801","article-title":"Bismuth salts with versus without acid suppression for Helicobacter pylori infection: a transmission electron microscope study","volume":"26","author":"Chiang","year":"2021","journal-title":"Helicobacter"},{"issue":"6","key":"10.1016\/j.clnesp.2024.11.016_bib12","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12846","article-title":"Integrative proteomic and metabolomic analyses reveal the mechanism by which bismuth enables Helicobacter pylori eradication","volume":"26","author":"Yao","year":"2021","journal-title":"Helicobacter"},{"issue":"6","key":"10.1016\/j.clnesp.2024.11.016_bib13","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2146\/ajhp090168","article-title":"Probiotics","volume":"67","author":"Williams","year":"2010","journal-title":"Am J Health Syst Pharm"},{"issue":"4","key":"10.1016\/j.clnesp.2024.11.016_bib14","doi-asserted-by":"crossref","first-page":"384","DOI":"10.4291\/wjgp.v5.i4.384","article-title":"Use of probiotics in the fight against Helicobacter pylori","volume":"5","author":"Ruggiero","year":"2014","journal-title":"World J Gastrointest Pathophysiol"},{"issue":"4","key":"10.1016\/j.clnesp.2024.11.016_bib15","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1523-5378.2008.00601.x","article-title":"The effects of probiotics on PPI-triple therapy for Helicobacter pylori eradication","volume":"13","author":"Kim","year":"2008","journal-title":"Helicobacter"},{"issue":"10","key":"10.1016\/j.clnesp.2024.11.016_bib16","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1111\/j.1365-2036.2004.02274.x","article-title":"Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial","volume":"20","author":"Nista","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.clnesp.2024.11.016_bib17","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1523-5378.2007.00516.x","article-title":"Efficacy and safety of Saccharomyces boulardii in the 14-day triple anti-Helicobacter pylori therapy: a prospective randomized placebo-controlled double-blind study","volume":"12","author":"Cindoruk","year":"2007","journal-title":"Helicobacter"},{"issue":"3","key":"10.1016\/j.clnesp.2024.11.016_bib18","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/hel.12270","article-title":"The effect of probiotics on gut microbiota during the Helicobacter pylori eradication: randomized controlled trial","volume":"21","author":"Oh","year":"2016","journal-title":"Helicobacter"},{"issue":"4","key":"10.1016\/j.clnesp.2024.11.016_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0034938","article-title":"A\u00a0meta-analysis of probiotic efficacy for gastrointestinal diseases","volume":"7","author":"Ritchie","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.clnesp.2024.11.016_bib20","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1177\/1756283X12459294","article-title":"Effects of probiotics on gut microbiota: mechanisms of intestinal immunomodulation and neuromodulation","volume":"6","author":"Hemarajata","year":"2013","journal-title":"Therap Adv Gastroenterol"},{"issue":"6","key":"10.1016\/j.clnesp.2024.11.016_bib21","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.anaerobe.2009.09.002","article-title":"Evidence-based review of probiotics for antibiotic-associated diarrhea and Clostridium difficile infections","volume":"15","author":"McFarland","year":"2009","journal-title":"Anaerobe"},{"issue":"6","key":"10.1016\/j.clnesp.2024.11.016_bib22","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/j.1365-2036.2007.03442.x","article-title":"Review article: yeast as probiotics -- Saccharomyces boulardii","volume":"26","author":"Czerucka","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"issue":"11","key":"10.1016\/j.clnesp.2024.11.016_bib23","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1001\/jama.1996.03530350052034","article-title":"Biotherapeutic agents. A neglected modality for the treatment and prevention of selected intestinal and vaginal infections","volume":"275","author":"Elmer","year":"1996","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.clnesp.2024.11.016_bib24","article-title":"Antimicrobial efficacy of five probiotic strains against Helicobacter pylori","volume":"9","author":"Saracino","year":"2020","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.clnesp.2024.11.016_bib25","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1471-2180-12-38","article-title":"Lactobacillus acidophilus ameliorates H. pylori-induced gastric inflammation by inactivating the Smad7 and NF\u03baB pathways","volume":"12","author":"Yang","year":"2012","journal-title":"BMC Microbiol"},{"issue":"3","key":"10.1016\/j.clnesp.2024.11.016_bib26","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12806","article-title":"Lactobacillus rhamnosus JB3 inhibits Helicobacter pylori infection through multiple molecular actions","volume":"26","author":"Do","year":"2021","journal-title":"Helicobacter"},{"issue":"9","key":"10.1016\/j.clnesp.2024.11.016_bib27","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1046\/j.1365-2036.2002.01335.x","article-title":"Impact of supplement with Lactobacillus- and Bifidobacterium-containing yogurt on triple therapy for Helicobacter pylori eradication","volume":"16","author":"Sheu","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.clnesp.2024.11.016_bib28","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12590","article-title":"The eradication of Helicobacter pylori restores rather than disturbs the gastrointestinal microbiota in asymptomatic young adults","volume":"24","author":"He","year":"2019","journal-title":"Helicobacter"},{"issue":"9","key":"10.1016\/j.clnesp.2024.11.016_bib29","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1136\/gutjnl-2019-319696","article-title":"Effect of Helicobacter pylori on gastrointestinal microbiota: a population-based study in Linqu, a high-risk area of gastric cancer","volume":"69","author":"Guo","year":"2020","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.clnesp.2024.11.016_bib30","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1177\/2050640615617358","article-title":"Systematic review and meta-analysis: multi-strain probiotics as adjunct therapy for Helicobacter pylori eradication and prevention of adverse events","volume":"4","author":"McFarland","year":"2016","journal-title":"United European Gastroenterol J"},{"issue":"1","key":"10.1016\/j.clnesp.2024.11.016_bib31","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3748\/wjg.v24.i1.139","article-title":"Probiotic monotherapy and Helicobacter pylori eradication: a systematic review with pooled-data analysis","volume":"24","author":"Losurdo","year":"2018","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clnesp.2024.11.016_bib32","first-page":"n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page M.J., McKenzie JE., Bossuyt P.M., Boutron I., Hoffmann T.C., Mulrow C.D.,","year":"2021","journal-title":"Br Med J"},{"key":"10.1016\/j.clnesp.2024.11.016_bib33","series-title":"Cochrane Handbook for systematic reviews of interventions","author":"Higgins","year":"2022"},{"key":"10.1016\/j.clnesp.2024.11.016_bib34","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"Br Med J"},{"issue":"1","key":"10.1016\/j.clnesp.2024.11.016_bib35","doi-asserted-by":"crossref","first-page":"34","DOI":"10.7704\/kjhugr.2022.0051","article-title":"Probiotic supplementation for treatment of Helicobacter pylori infection: a double-blind randomized clinical trial","volume":"23","author":"Lim","year":"2023","journal-title":"Korean J Helicobacter Up Gastrointest Res"},{"issue":"5","key":"10.1016\/j.clnesp.2024.11.016_bib36","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/s41591-019-0439-x","article-title":"The pros, cons, and many unknowns of probiotics","volume":"25","author":"Suez","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.clnesp.2024.11.016_bib37","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.copbio.2020.01.005","article-title":"Molecular mechanisms of probiotic prevention of antibiotic-associated diarrhea","volume":"61","author":"Mekonnen","year":"2020","journal-title":"Curr Opin Biotechnol"},{"key":"10.1016\/j.clnesp.2024.11.016_bib38","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.micres.2016.07.001","article-title":"Bifidobacteria-Insight into clinical outcomes and mechanisms of its probiotic action","volume":"192","author":"Sarkar","year":"2016","journal-title":"Microbiol Res"},{"issue":"3","key":"10.1016\/j.clnesp.2024.11.016_bib39","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1089\/jmf.2009.1265","article-title":"In\u00a0vitro inhibition of Helicobacter pylori growth and of adherence of cagA-positive strains to gastric epithelial cells by Lactobacillus paraplantarum KNUC25 isolated from kimchi","volume":"13","author":"Ki","year":"2010","journal-title":"J\u00a0Med Food"},{"issue":"2","key":"10.1016\/j.clnesp.2024.11.016_bib40","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000496426","article-title":"Beneficial effects of probiotic consumption on the immune system","volume":"74","author":"Maldonado Galdeano","year":"2019","journal-title":"Ann Nutr Metab"},{"issue":"1","key":"10.1016\/j.clnesp.2024.11.016_bib41","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1136\/gut.41.1.49","article-title":"Prevention of Helicobacter pylori infection by lactobacilli in a gnotobiotic murine model","volume":"41","author":"Kabir","year":"1997","journal-title":"Gut"},{"issue":"11","key":"10.1016\/j.clnesp.2024.11.016_bib42","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1128\/AAC.45.11.3156-3161.2001","article-title":"In\u00a0vitro anti-Helicobacter pylori activity of the probiotic strain Bacillus subtilis 3 is due to secretion of antibiotics","volume":"45","author":"Pinchuk","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"10.1016\/j.clnesp.2024.11.016_bib43","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1139\/w05-044","article-title":"In\u00a0vitro inhibition of Helicobacter pylori by Enterococcus faecium GM-1","volume":"51","author":"Kang","year":"2005","journal-title":"Can J Microbiol"},{"key":"10.1016\/j.clnesp.2024.11.016_bib44","doi-asserted-by":"crossref","first-page":"104403","DOI":"10.1016\/j.micpath.2020.104403","article-title":"Meta-analysis of the efficacy of probiotic-supplemented therapy on the eradication of H. pylori and incidence of therapy-associated side effects","volume":"147","author":"Zhang","year":"2020","journal-title":"Microb Pathog"},{"issue":"15","key":"10.1016\/j.clnesp.2024.11.016_bib45","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000015180","article-title":"Efficacy and safety of probiotics in eradicating Helicobacter pylori: a network meta-analysis","volume":"98","author":"Shi","year":"2019","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.clnesp.2024.11.016_bib46","doi-asserted-by":"crossref","first-page":"23522","DOI":"10.1038\/srep23522","article-title":"Probiotic supplementation does not improve eradication rate of Helicobacter pylori infection compared to placebo based on standard therapy: a meta-analysis","volume":"6","author":"Lu","year":"2016","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.clnesp.2024.11.016_bib47","doi-asserted-by":"crossref","first-page":"281","DOI":"10.23736\/S0026-4806.20.06810-X","article-title":"Treatment of Helicobacter pylori infection: a clinical practice update","volume":"112","author":"Zagari","year":"2021","journal-title":"Minerva Med"},{"issue":"3","key":"10.1016\/j.clnesp.2024.11.016_bib48","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1136\/gutjnl-2021-326170","article-title":"Cross-roads for meta-analysis and network meta-analysis of H. pylori therapy","volume":"71","author":"Graham","year":"2022","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.clnesp.2024.11.016_bib49","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.cgh.2021.03.026","article-title":"Primer for development of guidelines for Helicobacter pylori therapy using antimicrobial stewardship","volume":"20","author":"Graham","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"10","key":"10.1016\/j.clnesp.2024.11.016_bib50","article-title":"Transitioning of Helicobacter pylori therapy from trial and error to antimicrobial stewardship","volume":"9","author":"Graham","year":"2020","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.clnesp.2024.11.016_bib51","doi-asserted-by":"crossref","first-page":"3409820","DOI":"10.1155\/2019\/3409820","article-title":"Role of probiotics in Helicobacter pylori eradication: lessons from a study of lactobacillus reuteri strains DSM 17938 and ATCC PTA 6475 (Gastrus\u00ae) and a proton-pump inhibitor","volume":"2019","author":"Dore","year":"2019","journal-title":"Can J Infect Dis Med Microbiol"},{"issue":"2","key":"10.1016\/j.clnesp.2024.11.016_bib52","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12476","article-title":"Brief report: lactobacillus bulgaricus GLB44 (Proviotic(\u2122)) plus esomeprazole for Helicobacter pylori eradication: a pilot study","volume":"23","author":"Opekun","year":"2018","journal-title":"Helicobacter"},{"issue":"4","key":"10.1016\/j.clnesp.2024.11.016_bib53","doi-asserted-by":"crossref","first-page":"518","DOI":"10.4014\/jmb.1205.05018","article-title":"Effect of probiotics Lactobacillus and Bifidobacterium on gut-derived lipopolysaccharides and inflammatory cytokines: an in\u00a0vitro study using a human colonic microbiota model","volume":"23","author":"Rodes","year":"2013","journal-title":"J\u00a0Microbiol Biotechnol"},{"issue":"10","key":"10.1016\/j.clnesp.2024.11.016_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0163743","article-title":"Efficacy of probiotic supplementation therapy for Helicobacter pylori eradication: a meta-analysis of randomized controlled trials","volume":"11","author":"L\u00fc","year":"2016","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.clnesp.2024.11.016_bib55","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1365-2036.2006.03179.x","article-title":"Meta-analysis: the effect of supplementation with probiotics on eradication rates and adverse events during Helicobacter pylori eradication therapy","volume":"25","author":"Tong","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.clnesp.2024.11.016_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00394-010-0166-z","article-title":"Health benefits of probiotics: are mixtures more effective than single strains?","volume":"50","author":"Chapman","year":"2011","journal-title":"Eur J Nutr"},{"issue":"8","key":"10.1016\/j.clnesp.2024.11.016_bib57","doi-asserted-by":"crossref","first-page":"445","DOI":"10.4321\/S1130-01082013000800002","article-title":"Lactobacillus-containing probiotic supplementation increases Helicobacter pylori eradication rate: evidence from a meta-analysis","volume":"105","author":"Zheng","year":"2013","journal-title":"Rev Esp Enferm Dig"},{"issue":"Suppl 1","key":"10.1016\/j.clnesp.2024.11.016_bib58","first-page":"S99","article-title":"The efficacy and safety of adding the probiotic Saccharomyces boulardiito standard triple therapy for eradication of H.pylori: a randomized controlled trial","volume":"6","author":"Zojaji","year":"2013","journal-title":"Gastroenterol Hepatol Bed Bench"},{"issue":"4","key":"10.1016\/j.clnesp.2024.11.016_bib59","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1523-5378.2012.00944.x","article-title":"Helicobacter pylori infection in clinical practice: probiotics and a combination of probiotics\u00a0+ lactoferrin improve compliance, but not eradication, in sequential therapy","volume":"17","author":"Manfredi","year":"2012","journal-title":"Helicobacter"},{"issue":"5","key":"10.1016\/j.clnesp.2024.11.016_bib60","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12651","article-title":"Saccharomyces boulardii as an adjuvant therapy for Helicobacter pylori eradication: a systematic review and meta-analysis with trial sequential analysis","volume":"24","author":"Zhou","year":"2019","journal-title":"Helicobacter"},{"issue":"9","key":"10.1016\/j.clnesp.2024.11.016_bib61","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1365-2036.2010.04457.x","article-title":"Meta-analysis: the effects of Saccharomyces boulardii supplementation on Helicobacter pylori eradication rates and side effects during treatment","volume":"32","author":"Szajewska","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"issue":"37","key":"10.1016\/j.clnesp.2024.11.016_bib62","doi-asserted-by":"crossref","first-page":"10644","DOI":"10.3748\/wjg.v21.i37.10644","article-title":"Are probiotics useful in Helicobacter pylori eradication?","volume":"21","author":"Homan","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"5","key":"10.1016\/j.clnesp.2024.11.016_bib63","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1007\/s00213-019-05248-6","article-title":"Gut microbiota and bipolar disorder: a review of mechanisms and potential targets for adjunctive therapy","volume":"236","author":"Gondalia","year":"2019","journal-title":"Psychopharmacology (Berl)"},{"issue":"4","key":"10.1016\/j.clnesp.2024.11.016_bib64","first-page":"Cd004827","article-title":"Probiotics for the prevention of pediatric antibiotic-associated diarrhea","volume":"4","author":"Johnston","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.clnesp.2024.11.016_bib65","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s40168-019-0632-7","article-title":"Oral administration of antibiotics increased the potential mobility of bacterial resistance genes in the gut of the fish Piaractus mesopotamicus","volume":"7","author":"S\u00e1enz","year":"2019","journal-title":"Microbiome"},{"issue":"Suppl 1","key":"10.1016\/j.clnesp.2024.11.016_bib66","article-title":"Treatment of Helicobacter pylori infection in 2018","volume":"23","author":"O\u2019Morain","year":"2018","journal-title":"Helicobacter"},{"issue":"16","key":"10.1016\/j.clnesp.2024.11.016_bib68","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1517\/14656566.8.16.2701","article-title":"Treatment strategy to eradicate Helicobacter pylori infection: impact of pharmacogenomics-based acid inhibition regimen and alternative antibiotics","volume":"8","author":"Sugimoto","year":"2007","journal-title":"Expet Opin Pharmacother"},{"key":"10.1016\/j.clnesp.2024.11.016_bib69","doi-asserted-by":"crossref","first-page":"759249","DOI":"10.3389\/fphar.2021.759249","article-title":"Influence of Cytochrome P450 2C19 genotype on Helicobacter pylori proton pump inhibitor-amoxicillin-clarithromycin eradication therapy: a meta-analysis","volume":"12","author":"Morino","year":"2021","journal-title":"Front Pharmacol"},{"issue":"2","key":"10.1016\/j.clnesp.2024.11.016_bib70","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12788","article-title":"Impact of body size on first-line Helicobacter pylori eradication success using vonoprazan and amoxicillin dual therapy","volume":"26","author":"Eto","year":"2021","journal-title":"Helicobacter"},{"issue":"11","key":"10.1016\/j.clnesp.2024.11.016_bib71","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1007\/s11695-008-9477-z","article-title":"The eradication of Helicobacter pylori is affected by body mass index (BMI)","volume":"18","author":"Abdullahi","year":"2008","journal-title":"Obes Surg"},{"issue":"3","key":"10.1016\/j.clnesp.2024.11.016_bib72","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1159\/000446300","article-title":"Different pathophysiology of gastritis in east and west? A western perspective","volume":"1","author":"Wirth","year":"2016","journal-title":"Inflamm Intest Dis"},{"issue":"5","key":"10.1016\/j.clnesp.2024.11.016_bib73","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1053\/j.gastro.2018.07.007","article-title":"Prevalence of antibiotic resistance in Helicobacter pylori: a systematic review and meta-analysis in world health organization regions","volume":"155","author":"Savoldi","year":"2018","journal-title":"Gastroenterology"}],"container-title":["Clinical Nutrition ESPEN"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457724015250?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457724015250?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T11:07:40Z","timestamp":1740740860000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405457724015250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":72,"alternative-id":["S2405457724015250"],"URL":"https:\/\/doi.org\/10.1016\/j.clnesp.2024.11.016","relation":{},"ISSN":["2405-4577"],"issn-type":[{"value":"2405-4577","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of probiotics regimens for Helicobacter pylori eradication: A\u00a0systematic review, pairwise, and network meta-analysis of randomized controlled trials","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition ESPEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnesp.2024.11.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd on behalf of European Society for Clinical Nutrition and Metabolism.","name":"copyright","label":"Copyright"}]}}